- Home
- ABVC vs ALUR Comparison
ABVC vs ALUR Comparison
Compare ABVC & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- ALUR
- Stock Information
- Founded
- ABVC 2015
- ALUR 2009
- Country
- ABVC United States
- ALUR United States
- Employees
- ABVC N/A
- ALUR N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- ABVC Health Care
- ALUR
- Exchange
- ABVC Nasdaq
- ALUR Nasdaq
- Market Cap
- ABVC 16.7M
- ALUR 19.1M
- IPO Year
- ABVC N/A
- ALUR N/A
- Fundamental
- Price
- ABVC $0.98
- ALUR $2.40
- Analyst Decision
- ABVC
- ALUR Strong Buy
- Analyst Count
- ABVC 0
- ALUR 3
- Target Price
- ABVC N/A
- ALUR $22.83
- AVG Volume (30 Days)
- ABVC 655.9K
- ALUR 120.0K
- Earning Date
- ABVC 04-15-2025
- ALUR 05-13-2025
- Dividend Yield
- ABVC N/A
- ALUR N/A
- EPS Growth
- ABVC N/A
- ALUR N/A
- EPS
- ABVC N/A
- ALUR N/A
- Revenue
- ABVC $509,588.00
- ALUR $32,110,000.00
- Revenue This Year
- ABVC $735.18
- ALUR N/A
- Revenue Next Year
- ABVC N/A
- ALUR $38.86
- P/E Ratio
- ABVC N/A
- ALUR N/A
- Revenue Growth
- ABVC 234.31
- ALUR N/A
- 52 Week Low
- ABVC $0.40
- ALUR $2.15
- 52 Week High
- ABVC $1.73
- ALUR $88.75
- Technical
- Relative Strength Index (RSI)
- ABVC 56.38
- ALUR 41.46
- Support Level
- ABVC $0.81
- ALUR $2.18
- Resistance Level
- ABVC $1.00
- ALUR $2.41
- Average True Range (ATR)
- ABVC 0.16
- ALUR 0.24
- MACD
- ABVC -0.01
- ALUR 0.01
- Stochastic Oscillator
- ABVC 39.92
- ALUR 31.43
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.